Connect with us

Health

World News | Longer Gap in Pfizer-BioNTech COVID Vaccines Boosts Antibody Levels: Study – LatestLY

Get latest articles and stories on World at LatestLY. A longer gap between first and second doses of the Pfizer-BioNTech COVID-19…

Published

on

Article feature image
ADVERTISEMENT

London, Jul 24 (PTI) A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending